Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Melanoma × Cetuximab × Clear all

Phase

Status

Completed 4 Recruiting 2 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Dermatologic 1

Conditions

Colorectal Neoplasms 43 Squamous Cell Carcinoma of Head and Neck 21 Head and Neck Neoplasms 20 Rectal Neoplasms 16 Colonic Neoplasms 14 Neoplasm Metastasis 12 Neoplasms 11 Carcinoma, Squamous Cell 10 Carcinoma, Non-Small-Cell Lung 9 Pancreatic Neoplasms 5 Recurrence 4 Esophageal Neoplasms 4 Laryngeal Neoplasms 3 Laryngeal Diseases 3 Tongue Neoplasms 2 Stomach Neoplasms 2 Ovarian Neoplasms 2 Oropharyngeal Neoplasms 2 Neoplasms, Squamous Cell 2 Mouth Neoplasms 2 Lung Neoplasms 2 Hereditary Sensory and Autonomic Neuropathies 2 Glioma 2 Glioblastoma 2 Colorectal Cancer Metastatic 2 Breast Neoplasms 2 Adenocarcinoma of Lung 2 Adenocarcinoma Of Esophagus 2 Uterine Cervical Neoplasms 1 Sarcoma 1

Interventions

pembrolizumab 49 Ipilimumab 47 Cyclophosphamide 43 Nivolumab 38 aldesleukin 30 Interleukin-2 23 Vemurafenib 20 fludarabine 19 Temozolomide 18 fludarabine phosphate 15 dabrafenib 15 trametinib 12 Dacarbazine 10 spartalizumab 9 cobimetinib 9 binimetinib 9 Radiotherapy 9 Radiosurgery 9 CTLA-4 Antigen 9 poly ICLC 7 encorafenib 7 atezolizumab 6 Paclitaxel 6 Introns 6 Biopsy 6 montanide ISA 51 5 epacadostat 4 MART-1 Antigen 4 Interferon alpha-2 4 Immunohistochemistry 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03009058 2024-11-25

MODULATE

Immodulon Therapeutics Ltd

Phase 1/2 Terminated

2 enrolled 7 charts

DermatologicSarcoma

Melanoma, Neoplasm Metastasis, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡